FY2025 · ended Dec 31, 2025 · Revenue $3.94M, +20.4% YoY · Filed Mar 27, 2026
Tenon Medical, Inc (TNON) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.9 million and a net loss of $12.6 million. Free cash flow was -$11.0 million. As of Jun 30, 2026 it held $1.7 million in cash and investments and $1.3 million in total debt.
Revenue (TTM)
$5.31M
+80.3% vs year-ago TTM
Net income (TTM)
$-13.70M
-8.2% vs year-ago TTM
Operating cash flow (TTM)
$-11.77M
-19.9% vs year-ago TTM
Free cash flow (TTM)
$-12.07M
-19.8% vs year-ago TTM
EPS (TTM)
$-1,834.68
+84.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
11.30M
+102.3% vs prior year
Net cash
$331,000
as of Jun 30, 2026
Operating margin
-242.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TNON (Nasdaq), TNONW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Gatos, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1560293
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | $3.9M | $3.3M | $2.9M | $691,000 |
| Operating income | -$12.8M | -$13.8M | -$15.7M | -$18.7M |
| Net income | -$12.6M | -$13.7M | -$15.6M | -$18.9M |
| Diluted EPS | -$1.70 | -$11.26 | -$68.64 | -$23.62 |
| Operating cash flow | -$10.7M | -$9.9M | -$12.2M | -$12.0M |
| Free cash flow | -$11.0M | -$10.1M | — | -$12.9M |
| Total assets | $10.8M | $9.8M | $6.3M | $11.1M |
| Total liabilities | $5.7M | $3.9M | $5.6M | $4.8M |
| Stockholders' equity | $5.0M | $6.0M | $778,000 | $6.3M |
| Cash and investments | $3.8M | $6.5M | $2.4M | $8.6M |
| Total debt | $141,000 | $428,000 | $684,000 | $911,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Oct 22, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 16, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 31, 2026 | Aug 27, 2026 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Other events
|
Aug 26, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Other events
|
Aug 24, 2026 | Aug 24, 2026 |
All 300 Tenon Medical, Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.